Document is current
Any future updates will be listed below
-
Authors
Thellin, Olivier http://orcid.org/0000-0001-6353-8332
Elmoualij, Benaïssa
Zorzi, Willy
Jensen, Jorgen S.
Close, Renaud
Deregowski, Valerie
Le Guern Fellous, Muriel
Quatresooz, Pascale
-
Funding
Funding for this research was provided by:
Région Wallonne (Not applicable)
Diagenode s.a. (Not applicable)
- License Information
-
More Information
Article History
Received: 13 May 2019
Accepted: 29 August 2019
First Online: 23 September 2019
Ethics approval and consent to participate
: There is no need for ethical approval of the study itself by an Ethical Review Board as it involves only de-identified samples. As samples were anonymized and were examined here with the same purpose as they were originally submitted, the study is considered quality assurance or quality development and thus, ethics approval and consent to participate are not needed according to Danish law no. 593 of 14. June 2011 with subsequent amendments about ethics approval of research in health sciences.
: Not applicable.
: PQ has no conflicts of interest to declare. OT, BE and WZ received part of their funding for this study from Diagenode s.a. JSJ has received a speaker’s fee from Hologic, BD and Cepheid, and serves on the scientific advisory boards of Roche Molecular Systems, Abbott Molecular and Cepheid. The Statens Serum Institut has received remuneration for contract work from SpeeDx, Hologic, NYTor, Diagenode, Abbott, Nabriva, GSK and Angelini. This does not alter its adherence to the journal’s policies on sharing data and materials. RC, VD and MLGF are employees of Diagenode s.a.
